Metagenomi Therapeutics, Inc. (MGX): 8-K filed May 11, 2026

Form type

8-K

Filing date

May 11, 2026

Accession number

0001193125-26-216763

Filer

Metagenomi Therapeutics, Inc. (CIK 1785279)